Anal fistula is a common disease that needs surgical treatment to be resolved. Despite a variety of surgical options, the major problem is still to cure complex fistulas without any recurrence in the long-term follow-up but, at the same time, to avoid an impairment of continence. In recent years, one solution has been the application of mesenchymal stem cells derived from adipose tissue, especially in association with other treatments, such as the use of fibrin glue or the previous application of a seton. Their initial use in fistulas associated with Crohn’s disease has shown encouraging results. In this non-systematic review our aim is to analyze the use in cryptoglandular fistulas: the rate of healing is not so high, and the number of studies is limited. Therefore, further randomized controlled trials are needed to establish their efficacy in the case of complex cryptoglandular anal fistulas and their possible complications.

Mesenchymal stem cells for cryptoglandular anal fistula: current state of art / Eberspacher, Chiara; Mascagni, Domenico; Ferent, Iulia Catalina; Coletta, Enrico; Palma, Rossella; Panetta, Cristina; Esposito, Anna; Arcieri, Stefano; Pontone, Stefano. - In: FRONTIERS IN SURGERY. - ISSN 2296-875X. - 9:(2022), pp. 1-6. [10.3389/fsurg.2022.815504]

Mesenchymal stem cells for cryptoglandular anal fistula: current state of art

Eberspacher, Chiara;Mascagni, Domenico;Ferent, Iulia Catalina;Coletta, Enrico;Palma, Rossella;Panetta, Cristina;Esposito, Anna;Arcieri, Stefano;Pontone, Stefano
2022

Abstract

Anal fistula is a common disease that needs surgical treatment to be resolved. Despite a variety of surgical options, the major problem is still to cure complex fistulas without any recurrence in the long-term follow-up but, at the same time, to avoid an impairment of continence. In recent years, one solution has been the application of mesenchymal stem cells derived from adipose tissue, especially in association with other treatments, such as the use of fibrin glue or the previous application of a seton. Their initial use in fistulas associated with Crohn’s disease has shown encouraging results. In this non-systematic review our aim is to analyze the use in cryptoglandular fistulas: the rate of healing is not so high, and the number of studies is limited. Therefore, further randomized controlled trials are needed to establish their efficacy in the case of complex cryptoglandular anal fistulas and their possible complications.
2022
cryptoglandular anal fistula; complication; recurrence; fecal incontinence; stem cells
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Mesenchymal stem cells for cryptoglandular anal fistula: current state of art / Eberspacher, Chiara; Mascagni, Domenico; Ferent, Iulia Catalina; Coletta, Enrico; Palma, Rossella; Panetta, Cristina; Esposito, Anna; Arcieri, Stefano; Pontone, Stefano. - In: FRONTIERS IN SURGERY. - ISSN 2296-875X. - 9:(2022), pp. 1-6. [10.3389/fsurg.2022.815504]
File allegati a questo prodotto
File Dimensione Formato  
Eberspacher_Mesenchymal_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 356.14 kB
Formato Adobe PDF
356.14 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1611621
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 2
social impact